Instructions for Use
- Stand in front of a mirror and locate your sternum (breastbone).
- Try a few different spots on your sternum to find the most comfortable place for your CUE1 to sit.
- ⚠ Please ensure that the area is kept clean and dry. Trim and excess chest hair to ensure that the adhesive attaches.
- ⚠ When in normal use, the patient’s skin will be in contact with the silicone. Please ensure that you do not have any allergic reactions to silicone.
- Place your CUE1 into the adhesive drawer, so that the device picks up one adhesive. This will help you remove adhesives more easily from the drawer.
- Please peel off the adhesive’s backings, remaining careful not to fold the the sticky side back on itself.
- Place your CUE1 on the preferred location and ensure that the adhesive is fully attached by applying pressure to the edge of the adhesive with your finger.
Parkinson’s is a neurodegenerative disorder affecting 10 million people worldwide. Despite the best available medical and surgical interventions, people with Parkinson’s are often frustrated, as they remain significantly limited in their activities. Charco Neurotech, established in 2019 by Lucy Jung and Floyd Pierres, was founded with one ambition: to bring back smiles for people with Parkinson’s. This led to our design of the CUE1, a non-invasive wearable device. The CUE1 alleviates certain Parkinson’s symptoms, including stiffness and slowness of movement. It achieves this by utilising two vibration-based therapies: focused stimulation and cueing, both of which are research-validated. It also incorporates discreet medication reminders and an accompanying app, which enables the user to track their symptoms.
Parkinson’s affects everyone differently, and the support which Charco offers reflects this. Developments such as the CUE1 allow the person with Parkinson’s to be at the centre of their treatment, and tailor management of their symptoms to their own unique lives. During our pilot testing of the CUE1, we have consistently recorded average improvements during use of the device, with participants reporting smoother and quicker movements. Through these innovations, we hope to improve quality of life for all with Parkinson’s.